Ken Inoki
Impact in
- Aging top 0.2%
- Epidemiology top 0.2%
- Autophagy in Disease and Therapy
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 46
- Metabolism, Diabetes, and Cancer 8
- TGF-β signaling in diseases 3
- Nephrology 16
- Chronic Kidney Disease and Diabetes 9
- Renal Diseases and Glomerulopathies 9
- Co-authors
- Kun‐Liang Guan (30 shared papers)Tianqing Zhu (3 shared papers)Yong Li (5 shared papers)Tianquan Zhu (1 shared paper)Michael Nino Corradetti (2 shared papers)Joungmok Kim (1 shared paper)Tsuneo Ikenoue (7 shared papers)Qian Yang (3 shared papers)
- Journals
- Journal of Biological Chemistry (9 papers)Proceedings of the National Academy of Sciences (5 papers)Journal of the American Society of Nephrology (4 papers)Journal of Clinical Investigation (4 papers)Kidney International (4 papers)
- Partner nations
- United StatesJapanSingapore
In The Last Decade
Ken Inoki
96 papers receiving 22.7k citations
Ken Inoki's Hit Papers
Peers
Comparison fields: 5 of 154
- Aging 506
- Epidemiology 5.6k
- Nephrology 1.6k
- Molecular Biology 9.4k
- Cell Biology 1.3k
Countries citing papers authored by Ken Inoki
This map shows the geographic impact of Ken Inoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Inoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Inoki more than expected).
Fields of papers citing papers by Ken Inoki
This network shows the impact of papers produced by Ken Inoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Inoki. The network helps show where Ken Inoki may publish in the future.
Co-authors
The 25 scholars most cited alongside Ken Inoki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Guidelines for the use and interpretation of assays for monitoring autophagy Hit paper breakdown → | 2012 | 3543 |
| 2 | TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival Hit paper breakdown → | 2003 | 3303 |
| 3 | TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling Hit paper breakdown → | 2002 | 2569 |
| 4 | Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 Hit paper breakdown → | 2021 | 2067 |
| 5 | TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth Hit paper breakdown → | 2006 | 1154 |
| 6 | Dysregulation of the TSC-mTOR pathway in human disease Hit paper breakdown → | 2004 | 840 |
| 7 | AMPK and mTOR in Cellular Energy Homeostasis and Drug Targets Hit paper breakdown → | 2011 | 682 |
| 8 | ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS Hit paper breakdown → | 2010 | 636 |
| 9 | 2008 | 516 | |
| 10 | Spatial Coupling of mTOR and Autophagy Augments Secretory Phenotypes Hit paper breakdown → | 2011 | 494 |
| 11 | Role of mTOR in podocyte function and diabetic nephropathy in humans and mice Hit paper breakdown → | 2011 | 484 |
| 12 | mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice Hit paper breakdown → | 2011 | 479 |
| 13 | 2005 | 280 | |
| 14 | 2012 | 231 | |
| 15 | 2004 | 207 | |
| 16 | 2005 | 207 | |
| 17 | 2008 | 207 | |
| 18 | 2013 | 195 | |
| 19 | 2006 | 190 | |
| 20 | 2019 | 190 |
About Ken Inoki
Ken Inoki is a scholar working on Molecular Biology, Nephrology, Epidemiology, Physiology and Cell Biology, having authored 99 papers that have together received 23.1k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (46 papers), Autophagy in Disease and Therapy (14 papers), Chronic Kidney Disease and Diabetes (9 papers), Renal Diseases and Glomerulopathies (9 papers), Tuberous Sclerosis Complex Research (8 papers), Metabolism, Diabetes, and Cancer (8 papers), TGF-β signaling in diseases (3 papers) and Cellular transport and secretion (3 papers). The work is most often cited by research in Aging (506 citations), Epidemiology (5.6k citations), Nephrology (1.6k citations), Molecular Biology (9.4k citations) and Cell Biology (1.3k citations). Ken Inoki has collaborated with scholars based in United States, Japan and Singapore. Frequent co-authors include Kun‐Liang Guan, Tianqing Zhu, Yong Li, Tianquan Zhu, Michael Nino Corradetti, Joungmok Kim, Tsuneo Ikenoue, Qian Yang, Hongjiao Ouyang and Sei Yoshida. Their work appears in journals such as Journal of Biological Chemistry, Proceedings of the National Academy of Sciences, Journal of the American Society of Nephrology, Journal of Clinical Investigation and Kidney International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.